Literature DB >> 3036828

Class II genes of the human major histocompatibility complex. Comparisons of the DQ and DX alpha and beta genes.

A K Jonsson, J J Hyldig-Nielsen, B Servenius, D Larhammar, G Andersson, F Jörgensen, P A Peterson, L Rask.   

Abstract

The human major histocompatibility complex, HLA, contains the genes of several class II molecules. We present here the molecular maps of the DQ and DX subregions and analyze the sequences of the polymorphic DQ alpha and DQ beta genes as well as the DX alpha and DX beta genes. The DQ alpha and DQ beta genes are oriented in opposite directions, approximately 12 kilobases apart. The DX alpha and DX beta genes are similarly oriented about 8 kilobases. The exon-intron organizations of the DQ alpha and DX alpha genes are analogous to those of other class II alpha genes. Comparison of the DQ alpha gene sequence to three DQ alpha cDNA clones shows that amino acid replacements are predominantly located between residues 45 and 80 in the amino-terminal domain. Analysis of the frequency of silent and replacement substitutions indicates that there is little selection against replacements in DQ alpha first domains. The exons encoding the second domains of DQ alpha and DX alpha are virtually identical, suggesting that a gene conversion event has occurred between these genes. The DX beta gene is very similar to the DQ beta gene but differs in the cytoplasmic portion. The DX beta gene contains a separate exon of 24 nucleotides encoding the core of the cytoplasmic tail. This exon is not expressed in the DQ beta genes due to a nonfunctional splice junction. Comparison of the number of nucleotide substitutions in the DQ beta first and second domain exons suggests that little or no phenotypic selection acts on the first domain whereas the second domain is under strong selection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036828

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  DNA polymorphisms in the 5'-flanking region of the HLA-DQA1 gene.

Authors:  G Del Pozzo; C Perfetto; M N Ombra; G Z Ding; J Guardiola; A Maffei
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

Review 3.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

5.  Sequence of a novel HLA-DQB1 allele.

Authors:  C Tautz; P Zwollo; D G Marsh; X Baur
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Allele-specific expression of the cytoplasmic exon of HLA-DQB1 gene.

Authors:  S Senju; A Kimura; M Yasunami; N Kamikawaji; H Yoshizumi; Y Nishimura; T Sasazuki
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

8.  The Xenopus YB3 protein binds the B box element of the class III promoter.

Authors:  I Cohen; W F Reynolds
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

9.  Mapping and nucleotide sequence of a new HLA class II light chain gene, DQB3.

Authors:  A Ando; J Kawai; M Maeda; K Tsuji; J Trowsdale; H Inoko
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

10.  Exon-intron organization of Xenopus MHC class II beta chain genes.

Authors:  F Kobari; K Sato; B P Shum; S Tochinai; M Katagiri; T Ishibashi; L Du Pasquier; M F Flajnik; M Kasahara
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.